A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients [clinicaltrials:NCT00002236]
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients [clinicaltrials:NCT00002236]
Bio2RDF identifier
NCT00002236
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002236
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... e a day or three times a day.
brief title [clinicaltrials_vocabulary:brief-title]
A Study to Find the Best Dosin ...... navir in HIV-Positive Patients
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Patients are divided in ...... oad and CD4 cell
count.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
CD4 Lymphocyte Count
Delavirdine
Drug Administration Schedule
Drug Therapy, Combination
HIV Protease Inhibitors
Reverse Transcriptase Inhibitors
Viral Load
Zidovudine
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-06-23T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002236
official title [clinicaltrials_vocabulary:official-title]
An Open-Label, Parallel Group, ...... in HIV-1 Infected Individuals
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
M/3331/0072
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2000-04-01T00:00:00Z
identifier
clinicaltrials:NCT00002236
title
A Study to Find the Best Dosin ...... navir in HIV-Positive Patients
@en
type
label
A Study to Find the Best Dosin ...... s [clinicaltrials:NCT00002236]
@en